Takeda Pharmaceutical Co., Ltd. et al v. Impax Laboratories, Inc.,

Filing 53

ORDER re 50 Stipulation of Dismissal of Count XI (False Marking) without prejudice filed by Impax Laboratories, Inc. Motions terminated: 20 MOTION to Dismiss Count XI of Impax's Counterclaims filed by Takeda Pharmaceuticals America, Inc., Takeda Pharmaceutical Co., Ltd., Takeda Pharmaceuticals LLC. Signed by Judge Joseph C. Spero on 10/13/11. (klhS, COURT STAFF) (Filed on 10/14/2011)

Download PDF
1 2 3 4 5 6 7 8 UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF CALIFORNIA SAN FRANCISCO DIVISION 9 10 11 12 TAKEDA PHARMACEUTICAL CO., LTD., TAKEDA PHARMACEUTICALS NORTH AMERICA, INC., TAKEDA PHARMACEUTICALS LLC, AND TAKEDA PHARMACEUTICALS AMERICA, INC., 13 Plaintiffs, 14 Case No. 3:11-cv-01610-JCS [PROPOSED] ORDER ON STIPULATION OF DISMISSAL PURSUANT TO FED. R. CIV. P. 41(a)(1) and (c) Related Cases: 3:11-cv-00840-JCS 3:11-cv-01609-JCS v. 15 IMPAX LABORATORIES, INC., 16 Defendant. 17 18 19 Having considered the parties’ Stipulation of Dismissal of Count XI (False Marking) of Defendant Impax’s Counterclaims (“Count XI”), IT IS ORDERED that Count XI is hereby 21 dismissed without prejudice, with each party to bear its own costs. 22 SO ORDERED: 23 October 13 DATED: __________________, 2011 _______________________________________ THE HONORABLE JOSEPH C. SPERO o UNITED STATES MAGISTRATE JUDGE C. Sper e Joseph 27 28 A H ER FO Judg LI RT 26 R NIA NO 25 UNIT ED 24 ISTRIC ES D TC AT T RT U O S 20 N F D IS T IC T O R C la-1144345 [PROPOSED] ORDER ON STIPULATION OF DISMISSAL

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.

Why Is My Information Online?